19733-96-1 Usage
General Description
2-(6-methylpyridin-3-yl)acetic acid is a chemical compound with the molecular formula C9H9NO2. It belongs to the class of organic compounds known as phenylacetic acids, which are compounds containing a phenylacetic acid moiety. 2-(6-methylpyridin-3-yl)acetic acid is also known by the names 3-(2-(6-methylpyridin-3-yl)acetamido)benzoic acid and N-(2-carboxyethyl)picolinamide. 2-(6-methylpyridin-3-yl)acetic acid is used in the pharmaceutical industry as an intermediate in the synthesis of various drugs and active pharmaceutical ingredients. It is also used in research and development of new drugs and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 19733-96-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,7,3 and 3 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 19733-96:
(7*1)+(6*9)+(5*7)+(4*3)+(3*3)+(2*9)+(1*6)=141
141 % 10 = 1
So 19733-96-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H9NO2/c1-6-2-3-7(5-9-6)4-8(10)11/h2-3,5H,4H2,1H3,(H,10,11)
19733-96-1Relevant articles and documents
-
Suminov,S.I.
, (1968)
-
TETRAAZA-CYCLOPENTA[A]INDENYL DERIVATIVES
-
, (2015/01/09)
The present invention provides compounds of Formula (I) as M1 receptor positive allosteric modulators for the treatment of diseases mediated by the muscarinic M1 mediator.
SUSTAINED RELEASE COMPOSITION CONTAINING TETRAHYDROPYRIDO Y4, 3-b¨INDOLE DERIVATIVE AND PREPARATION METHOD OF DERIVATIVE
-
, (2012/03/08)
The present invention relates to a sustained-release composition containing 2,3,4,5-tetrahydro-2,8-dimethyl-5-[2-(6-methyl-3-pyridyl)ethyl]-1H-pyrido[4,3-b]indole or a pharmaceutically acceptable salt thereof as an active ingredient, preparation thereof and the compound. The composition is suitable for oral administration by one time per day, and achieves the peak plasma concentration at 1.0 to 3 hours after oral administration. The composition is suitable for manufacturing a medicament for treatment of cognitive dysfunction syndrome, Alzheimer's disease, Parkinson's disease, Huntington's disease, or senile dementia.